CD1d expression in glioblastoma is a promising target for NKT cell-based cancer immunotherapy.
Cancer Immunol Immunother
; 70(5): 1239-1254, 2021 May.
Article
in En
| MEDLINE
| ID: mdl-33128583
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Brain Neoplasms
/
Immunotherapy, Adoptive
/
Glioblastoma
/
Cancer Vaccines
/
Natural Killer T-Cells
/
Antigens, CD1d
Limits:
Aged
/
Animals
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Cancer Immunol Immunother
Journal subject:
ALERGIA E IMUNOLOGIA
/
NEOPLASIAS
/
TERAPEUTICA
Year:
2021
Type:
Article
Affiliation country:
Japan